Pricing Log in Create free account

Assembly Biosciences, Inc. (ASMB) vs Zura Bio Limited (ZURA)

Assembly Biosciences, Inc. and Zura Bio Limited are both Biotechnology companies. Assembly Biosciences, Inc. and Zura Bio Limited are of similar size ($418.8M and $410.2M). Zura Bio Limited has negative trailing earnings, so its P/E is not meaningful; Assembly Biosciences, Inc. trades at 19.7×. Zura Bio Limited has the higher net margin (0.00% vs −0.06%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Assembly Biosciences, Inc. leads on 7 and Zura Bio Limited on 4.

Valuation

Metric ASMB ZURA Biotechnology median
P/E 19.70 n/m 8.50
P/S 5.06 n/m 9.71
P/B 1.24 2.50 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 0.78 n/m 9.21
Earnings yield 5.08% (29.05%) (33.15%)
Free cash flow yield (10.18%) (16.75%) (25.50%)

Profitability

Metric ASMB ZURA Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (11.75%) 0.00% 0.00%
Net margin (0.06%) 0.00% 0.00%
Free cash flow margin (51.53%) 0.00% 0.00%
Return on equity (0.03%) (71.76%) (56.36%)
Return on assets (0.02%) (62.74%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ASMB ZURA Biotechnology median
Revenue growth (TTM) 125.12% — 6.02%
EPS growth (last fiscal year) 91.78% (76.67%) 30.26%
Revenue growth, 5-year CAGR 35.27% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ASMB ZURA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.99 12.90 4.72
Net debt to EBITDA 17.31 1.45 0.96

Dividend

Metric ASMB ZURA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ASMB ZURA Biotechnology median
Market cap 418.81m 410.15m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack